Compare COO & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | BAX |
|---|---|---|
| Founded | 1980 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 10.2B |
| IPO Year | 1994 | 1994 |
| Metric | COO | BAX |
|---|---|---|
| Price | $59.75 | $17.34 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 9 |
| Target Price | ★ $90.18 | $21.00 |
| AVG Volume (30 Days) | 2.1M | ★ 7.5M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | $2,532,800,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $6.66 | $1.96 |
| Revenue Next Year | $5.18 | $2.22 |
| P/E Ratio | $91.47 | ★ N/A |
| Revenue Growth | ★ 18.41 | 5.72 |
| 52 Week Low | $58.89 | $15.73 |
| 52 Week High | $89.83 | $32.04 |
| Indicator | COO | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 29.44 | 47.42 |
| Support Level | N/A | $15.95 |
| Resistance Level | $70.01 | $17.50 |
| Average True Range (ATR) | 1.60 | 0.76 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 12.81 | 45.95 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.